Avricore Health Inc Share Price Toronto S.E.
Equities
APH
CA92143R2046
Pharmaceuticals
Sales 2022 | 1.77M 1.29M 103M | Sales 2023 | 3.49M 2.55M 204M | Capitalization | 16.94M 12.38M 990M |
---|---|---|---|---|---|
Net income 2022 | - 0 0 | Net income 2023 | - 0 0 | EV / Sales 2022 | 17.3 x |
Net cash position 2022 | 591K 432K 34.5M | Net cash position 2023 | 247K 180K 14.4M | EV / Sales 2023 | 4.79 x |
P/E ratio 2022 |
-37.7
x | P/E ratio 2023 |
-24.1
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 90.31% |
Managers | Title | Age | Since |
---|---|---|---|
Hector Bremner
CEO | Chief Executive Officer | - | 31/12/18 |
Kiki Smith
DFI | Director of Finance/CFO | - | 05/08/19 |
Rodger Seccombe
CTO | Chief Tech/Sci/R&D Officer | - | 07/12/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Hall
CHM | Chairman | 71 | 19/01/16 |
Robert Sindelar
BRD | Director/Board Member | 71 | 26/03/18 |
Christine Hrudka
BRD | Director/Board Member | - | 20/06/23 |
1st Jan change | Capi. | |
---|---|---|
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |